Objectives: Determine the association between LUTS associated with BPH and metabolic syndrome. Methods: The study was conducted over 100 patient at Sohag university hospital. Results: Regarding the relation between BMI and LUTS we found that the mean of BPH volume&prostatic specific antigen was significantly higher in obese patients than normal and overweight patients. Regarding the relation between diabetes mellitus and LUTS we found that the mean flowrate was lower in diabetic patients than non diabetic patients. Regarding the relation between hypertension and LUTS we found that mean IPSS and PSA was higher in hypertensive patient than non hypertensive patients. Conclusion: BPH volume was significantly correlated with each of age, body mass index,waste circumference, triglyceride and cholestrol. IPSS was significantly correlated with body mass indx and diabetus mellitus.
Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F. Metabolic syndrome: from global epidemiology to individualized medicine. ClinPharmacolTher. 2007; 82 (5): 509–24.
Bostanci Y, Kazzazi A, Momtahen S, Laze J, Djavan B. Correlation between benign prostatic hyperplasia and inflammation. CurrOpin Urol. 2013; 23 (1): 5–10.
Rom M, Schatzl G, Swietek N, Rucklinger E, Kratzik C. Lower urinary tract symptoms and depression. BJU Int. 2012; 110 (11 Pt C): E918–21.
McConnell JD, Roehrborn CG, Bautista OM, Andriole GL, Jr, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349:2387–98.
Park YWon, Seung Ki Min, Jun Ho Lee. Relationship between Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Metabolic Syndrome in Korean Men. World J Mens Health 2012 December 30(3): 183-188.
Doğan Y, Fatih Uruç, Bekir Aras, Aytaç Şahin, Mithat Kıvrak, Ahmet Ürkmez, Numan Doğu Güner, Sabahattin Aydın. The relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia. Turkish Journal of Urology 2015; 41(1): 7-12.
Bhindi, B. et al. Obesity is associated with larger prostate volume but not with worse urinary symptoms: analysis of a large multiethnic cohort. Urology. 83, 81–87 (2014).
Rył A, Iwona Rotter, Tomasz Miazgowski, Marcin Słojewski, Barbara Dołęgowska, Anna Lubkowska and Maria Laszczyńska. Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?. Diabetol Metab Syndr (2015) 7:94.
Gacci M, Vignozzi L, Sebastianelli A, Salvi M, Giannessi C, De Nunzio C, et al. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation. Prostate Cancer Prostatic Dis. 2013;16:101–6.
Abdelaal, M., mohamed, E. N., & sayed, M. (2018). elation between Benign prostatic hyperplasia and Metabolic syndrom. Sohag Medical Journal, 22(3), 219-222. doi: 10.21608/smj.2018.33494
MLA
Mahmoud A.el-Aziz Abdelaal; El niser Rashed mohamed; Mohmed Dyaa sayed. "elation between Benign prostatic hyperplasia and Metabolic syndrom". Sohag Medical Journal, 22, 3, 2018, 219-222. doi: 10.21608/smj.2018.33494
HARVARD
Abdelaal, M., mohamed, E. N., sayed, M. (2018). 'elation between Benign prostatic hyperplasia and Metabolic syndrom', Sohag Medical Journal, 22(3), pp. 219-222. doi: 10.21608/smj.2018.33494
VANCOUVER
Abdelaal, M., mohamed, E. N., sayed, M. elation between Benign prostatic hyperplasia and Metabolic syndrom. Sohag Medical Journal, 2018; 22(3): 219-222. doi: 10.21608/smj.2018.33494